 Low-grade latent prostate cancer volume predictor clinical cancer incidence cell low-grade Gleason prostate cancer tissue risk transformation cell high-grade Gleason clinical cancer short period growth consequence volume low-grade latent cancer tissue prostate glands men age incidence rate high-grade clinical cancer years Autopsy incidence data white men black men conclusion tumor growth period years transformation rate similar black men white men high-grade cancers year low-grade latent cancer volume hypothesis infrequent occurrence clinical cancer high prevalence latent cancer steep rise clinical cancer incidence age slow rise latent cancer prevalence age disparities clinical cancer incidence populations similar latent cancer prevalence hypothesis low-grade cancer volume critical determinant clinical cancer risk